Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System.

Pistor, Maximilian; Hoepner, Andreas G F; Lin, Yanan; Jung, Simon; Bassetti, Claudio L; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2021). Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System. Annals of the rheumatic diseases, 80(12), pp. 1633-1635. BMJ Publishing Group 10.1136/annrheumdis-2021-220679

[img]
Preview
Text
Pistor__2021__Immunotherapies_and_COVID_19_mortality.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (533kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Pistor, Maximilian; Jung, Simon; Bassetti, Claudio L.A.; Chan, Andrew Hao-Kuang; Salmen, Anke and Hoepner, Robert

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0003-4967

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Chantal Kottler

Date Deposited:

08 Nov 2021 12:23

Last Modified:

15 Nov 2021 00:15

Publisher DOI:

10.1136/annrheumdis-2021-220679

PubMed ID:

34285050

Uncontrolled Keywords:

COVID-19 autoimmune diseases biological therapy therapeutics

BORIS DOI:

10.48350/160560

URI:

https://boris.unibe.ch/id/eprint/160560

Actions (login required)

Edit item Edit item
Provide Feedback